BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35286090)

  • 1. Targeting the Mitotic Kinesin KIF18A in Chromosomally Unstable Cancers: Hit Optimization Toward an In Vivo Chemical Probe.
    Tamayo NA; Bourbeau MP; Allen JR; Ashton KS; Chen JJ; Kaller MR; Nguyen TT; Nishimura N; Pettus LH; Walton M; Belmontes B; Moriguchi J; Chen K; McCarter JD; Hanestad K; Chung G; Ninniri MSS; Sun J; Poppe L; Spahr C; Hui J; Jia L; Wu T; Dahal UP; Edson KZ; Payton M
    J Med Chem; 2022 Mar; 65(6):4972-4990. PubMed ID: 35286090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosomally unstable tumor cells specifically require KIF18A for proliferation.
    Marquis C; Fonseca CL; Queen KA; Wood L; Vandal SE; Malaby HLH; Clayton JE; Stumpff J
    Nat Commun; 2021 Feb; 12(1):1213. PubMed ID: 33619254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small-molecule inhibition of kinesin KIF18A reveals a mitotic vulnerability enriched in chromosomally unstable cancers.
    Payton M; Belmontes B; Hanestad K; Moriguchi J; Chen K; McCarter JD; Chung G; Ninniri MS; Sun J; Manoukian R; Chambers S; Ho SM; Kurzeja RJM; Edson KZ; Dahal UP; Wu T; Wannberg S; Beltran PJ; Canon J; Boghossian AS; Rees MG; Ronan MM; Roth JA; Minocherhomji S; Bourbeau MP; Allen JR; Coxon A; Tamayo NA; Hughes PE
    Nat Cancer; 2024 Jan; 5(1):66-84. PubMed ID: 38151625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of the KIF18A alpha-4 helix as a therapeutic target for chromosomally unstable tumor cells.
    Schutt KL; Queen KA; Fisher K; Budington O; Mao W; Liu W; Gu X; Xiao Y; Aswad F; Joseph J; Stumpff J
    Front Mol Biosci; 2024; 11():1328077. PubMed ID: 38410188
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification of the KIF18A alpha-4 helix as a therapeutic target for chromosomally unstable tumor cells.
    Schutt K; Queen KA; Fisher K; Budington O; Mao W; Liu W; Xiao Y; Aswad F; Joseph J; Stumpff J
    bioRxiv; 2023 Oct; ():. PubMed ID: 37905069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of optimized inhibitors of the mitotic kinesin Kif18A.
    Braun J; Möckel MM; Strittmatter T; Marx A; Groth U; Mayer TU
    ACS Chem Biol; 2015 Feb; 10(2):554-60. PubMed ID: 25402598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of the neck-linker of KIF18A alters Microtubule subpopulation preference.
    Queen KA; Cario A; Berger CL; Stumpff J
    Mol Biol Cell; 2024 Jan; 35(1):ar3. PubMed ID: 37903223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Weakened APC/C activity at mitotic exit drives cancer vulnerability to KIF18A inhibition.
    Gliech CR; Yeow ZY; Tapias-Gomez D; Yang Y; Huang Z; Tijhuis AE; Spierings DC; Foijer F; Chung G; Tamayo N; Bahrami-Nejad Z; Collins P; Nguyen TT; Plata Stapper A; Hughes PE; Payton M; Holland AJ
    EMBO J; 2024 Mar; 43(5):666-694. PubMed ID: 38279026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The kinesin-8 motor Kif18A suppresses kinetochore movements to control mitotic chromosome alignment.
    Stumpff J; von Dassow G; Wagenbach M; Asbury C; Wordeman L
    Dev Cell; 2008 Feb; 14(2):252-62. PubMed ID: 18267093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kif18A uses a microtubule binding site in the tail for plus-end localization and spindle length regulation.
    Weaver LN; Ems-McClung SC; Stout JR; LeBlanc C; Shaw SL; Gardner MK; Walczak CE
    Curr Biol; 2011 Sep; 21(17):1500-6. PubMed ID: 21885282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical Biology of Mitotic Spindle Assembly Motors.
    Solon A; Ohi R
    Methods Mol Biol; 2022; 2415():151-165. PubMed ID: 34972952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germinal Cell Aplasia in Kif18a Mutant Male Mice Due to Impaired Chromosome Congression and Dysregulated BubR1 and CENP-E.
    Liu XS; Zhao XD; Wang X; Yao YX; Zhang LL; Shu RZ; Ren WH; Huang Y; Huang L; Gu MM; Kuang Y; Wang L; Lu SY; Chi J; Fen JS; Wang YF; Fei J; Dai W; Wang ZG
    Genes Cancer; 2010 Jan; 1(1):26-39. PubMed ID: 20981276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitotic centromere-associated kinesin (MCAK): a potential cancer drug target.
    Sanhaji M; Friel CT; Wordeman L; Louwen F; Yuan J
    Oncotarget; 2011 Dec; 2(12):935-47. PubMed ID: 22249213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinesin-binding protein ensures accurate chromosome segregation by buffering KIF18A and KIF15.
    Malaby HLH; Dumas ME; Ohi R; Stumpff J
    J Cell Biol; 2019 Apr; 218(4):1218-1234. PubMed ID: 30709852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aneuploidy renders cancer cells vulnerable to mitotic checkpoint inhibition.
    Cohen-Sharir Y; McFarland JM; Abdusamad M; Marquis C; Bernhard SV; Kazachkova M; Tang H; Ippolito MR; Laue K; Zerbib J; Malaby HLH; Jones A; Stautmeister LM; Bockaj I; Wardenaar R; Lyons N; Nagaraja A; Bass AJ; Spierings DCJ; Foijer F; Beroukhim R; Santaguida S; Golub TR; Stumpff J; Storchová Z; Ben-David U
    Nature; 2021 Feb; 590(7846):486-491. PubMed ID: 33505028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GTSE1 tunes microtubule stability for chromosome alignment and segregation by inhibiting the microtubule depolymerase MCAK.
    Bendre S; Rondelet A; Hall C; Schmidt N; Lin YC; Brouhard GJ; Bird AW
    J Cell Biol; 2016 Dec; 215(5):631-647. PubMed ID: 27881713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The kinesin-8 Kif18A dampens microtubule plus-end dynamics.
    Du Y; English CA; Ohi R
    Curr Biol; 2010 Feb; 20(4):374-80. PubMed ID: 20153196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinesin motor proteins as targets for cancer therapy.
    Huszar D; Theoclitou ME; Skolnik J; Herbst R
    Cancer Metastasis Rev; 2009 Jun; 28(1-2):197-208. PubMed ID: 19156502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole-genome doubling confers unique genetic vulnerabilities on tumour cells.
    Quinton RJ; DiDomizio A; Vittoria MA; Kotýnková K; Ticas CJ; Patel S; Koga Y; Vakhshoorzadeh J; Hermance N; Kuroda TS; Parulekar N; Taylor AM; Manning AL; Campbell JD; Ganem NJ
    Nature; 2021 Feb; 590(7846):492-497. PubMed ID: 33505027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exclusive destruction of mitotic spindles in human cancer cells.
    Visochek L; Castiel A; Mittelman L; Elkin M; Atias D; Golan T; Izraeli S; Peretz T; Cohen-Armon M
    Oncotarget; 2017 Mar; 8(13):20813-20824. PubMed ID: 28209915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.